- Home
- CGON vs AVDX Comparison
CGON vs AVDX Comparison
Compare CGON & AVDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGON
- AVDX
- Stock Information
- Founded
- CGON 2010
- AVDX 2000
- Country
- CGON United States
- AVDX United States
- Employees
- CGON N/A
- AVDX N/A
- Industry
- CGON
- AVDX EDP Services
- Sector
- CGON
- AVDX Technology
- Exchange
- CGON NYSE
- AVDX Nasdaq
- Market Cap
- CGON 1.3B
- AVDX 1.6B
- IPO Year
- CGON 2024
- AVDX 2021
- Fundamental
- Price
- CGON $20.64
- AVDX $7.60
- Analyst Decision
- CGON Strong Buy
- AVDX Hold
- Analyst Count
- CGON 10
- AVDX 15
- Target Price
- CGON $65.11
- AVDX $9.79
- AVG Volume (30 Days)
- CGON 1.3M
- AVDX 1.6M
- Earning Date
- CGON 05-08-2025
- AVDX 05-07-2025
- Dividend Yield
- CGON N/A
- AVDX N/A
- EPS Growth
- CGON N/A
- AVDX N/A
- EPS
- CGON N/A
- AVDX 0.04
- Revenue
- CGON $1,139,000.00
- AVDX $438,940,000.00
- Revenue This Year
- CGON N/A
- AVDX $6.34
- Revenue Next Year
- CGON $16,237.24
- AVDX $10.52
- P/E Ratio
- CGON N/A
- AVDX $192.31
- Revenue Growth
- CGON 461.08
- AVDX 15.29
- 52 Week Low
- CGON $14.80
- AVDX $6.61
- 52 Week High
- CGON $46.99
- AVDX $12.93
- Technical
- Relative Strength Index (RSI)
- CGON 43.38
- AVDX 42.05
- Support Level
- CGON $19.47
- AVDX $7.40
- Resistance Level
- CGON $20.63
- AVDX $7.93
- Average True Range (ATR)
- CGON 2.07
- AVDX 0.43
- MACD
- CGON 0.20
- AVDX -0.01
- Stochastic Oscillator
- CGON 48.59
- AVDX 32.02
About CGON CG ONCOLOGY INC
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
About AVDX AvidXchange Holdings Inc.
AvidXchange Holdings Inc is a provider of AP automation software and payment solutions for middle-market businesses and their suppliers. It generates the majority of its sales from Payment revenue followed by Software revenue and Services revenue. The company generates revenue in the United States.